Phase IIa Clinical Study of Recombinant Mycobacterium Tuberculosis Antigen ESAT6-CFP10
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Mycobacterium riyadhense (Primary) ; Tuberculin
- Indications Tuberculosis
- Focus Therapeutic Use
- Sponsors AnHui Longcom Biologic Pharmacy
Most Recent Events
- 05 Jan 2015 New trial record